Cyclerion Therapeutics focuses on developing treatments for serious diseases, such as Olinciguat and Praliciguat, sGC stimulators in clinical trials for cardiovascular and kidney diseases. Established in 2018, the company is based in Cambridge, Massachusetts.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing